Weight Loss Medication at Structure House
Over the past two years, starting with the FDA’s approval of Wegovy for weight loss in June 2021, our team at Structure House has been keeping a close eye on the clinical trials that — again and again — suggest that these medications (in the class of GLP-1 agonists) are gaining attention for good reason. Aside … Read More
